Comerica Bank
SLNO

Comerica Bank’s Soleno Therapeutics SLNO Stock Holding History

Comerica Bank’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$108K Sell
2,330
-164,496
-99% -$9.02M ﹤0.01% 2593
2025
Q3 		$11.3M Sell
166,826
-78,523
-32% -$5.82M 0.04% 395
2025
Q2 		$20.6M Buy
245,349
+57,256
+30% +$4.29M 0.08% 251
2025
Q1 		$13.4M Buy
188,093
+66,880
+55% +$3.26M 0.06% 325
2024
Q4 		$5.45M Buy
121,213
+85,823
+243% +$4.45M 0.02% 646
2024
Q3 		$1.79M Buy
+35,390
New +$1.69M 0.01% 1203

Other funds holding SLNO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Comerica Bank's SLNO Position: Q4 2025 in Review

Comerica Bank reduced its Soleno Therapeutics (SLNO) stake by 99% in Q4 2025, selling an estimated $9.02M and leaving 2,330 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #2593.

Comerica Bank first reported a position in SLNO in Q3 2024 and has held it in 6 quarters since. The position peaked at $20.6M in Q2 2025. 248 funds tracked by Wall St. Rank hold SLNO as of Q4 2025.

  • Comerica Bank held 2,330 shares of Soleno Therapeutics worth $108K as of Q4 2025.
  • Comerica Bank sold 164,496 Soleno Therapeutics shares in Q4 2025, an estimated $9.02M.
  • Soleno Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2593 holding.
  • Comerica Bank first reported a position in Soleno Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • Comerica Bank's Soleno Therapeutics position peaked at $20.6M in Q2 2025.
  • 248 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.